HEPA
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q1 2025 | 1 | -2 | 15.58K | $6,698 | +1 | −3 |
| Q4 2024 | 3 | -1 | 78.23K | $36,780 | — | −1 |
| Q3 2024 | 3 | +2 | 92.90K | $62,248 | +2 | — |
| Q2 2024 | 1 | — | 44.54K | $48,119 | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 15.58K | New | $6,698 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Citadel Advisors | $6,698 | 0.0% |
Exited
| Geode Capital Management | $21,248 | was 0.0% |
| Renaissance Technologies | $8,163 | was 0.0% |
| State Street Global Advisors | $7,369 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 1 shares, $0 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer, Director · Chief Operating… · 2.00M sh @ 0.05 · $100,000
Officer, Director · Executive Chairman · 8.00M sh @ 0.05 · $400,000
Officer, Director · Executive Chairman · 2.00M sh @ 0.05 · $100,000
Director · 2.00M sh @ 0.05 · $100,000
Officer, Director · Interim CEO · 2.00M sh @ 0.05 · $100,000
Director · 500.00K sh @ 0.05 · $25,000
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
21.4% of class · View original SEC filing ↗
5.7% of class · View original SEC filing ↗
5.7% of class · View original SEC filing ↗
11.1% of class · View original SEC filing ↗